Prometheus Biosciences

Prometheus Biosciences, Inc., formerly known as Prometheus Laboratories, Inc., is a biotechnology company based in San Diego, California, specializing in the development and commercialization of pharmaceutical and diagnostic products aimed at enhancing individualized patient care, particularly in the field of gastroenterology. The company offers a range of products, including therapeutic drug monitoring assays and diagnostic tests for inflammatory bowel disease (IBD), celiac disease, and other gastrointestinal disorders. Notable offerings include the Anser IFX and Anser ADA assays for monitoring drug levels and antibodies, as well as the IBD sgi Diagnostic test that combines various biomarkers for improved diagnostic accuracy. Prometheus also markets drugs like Entocort EC for Crohn's disease and provides testing services that assist healthcare providers in optimizing treatment strategies. With a commitment to innovation and precision medicine, Prometheus Biosciences is positioned for growth and expansion into new therapeutic areas.